SCHEMBL1876338

SCHEMBL1876338

CC1c2cc(Cl)ccc2C(=O)[C@]1(O)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
PPOX P50336 1/20 0.35
TYMS P04818 1/20 0.34
S100A4 P26447 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
AKR1B1 P15121 2/20 0.33
ATM Q13315 1/20 0.33
SLC6A9 P48067 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33
PKM P14618 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4950320 1.00 MEN1 (0.36) MEN1KMT2AALDH1A1TP53PPOX
SCHEMBL9589487 0.82 MEN1 (0.36) MEN1KMT2AALDH1A1TP53PPOX
SCHEMBL28355810 0.78 MEN1 (0.34) MEN1KMT2AALDH1A1TP53PPOX
SCHEMBL8872154 0.77 MEN1 (0.33) MEN1KMT2AALDH1A1TP53PPOX
SCHEMBL25834345 0.66 PPOX (0.41) MEN1KMT2AALDH1A1PPOXS100A4
SCHEMBL9587304 0.65 HTR2B (0.36) MEN1KMT2AALDH1A1PPOXTYMS
SCHEMBL2941707 0.64 SRD5A1 (0.45) ALDH1A1TP53PPOXS100A4CA1
SCHEMBL2947059 0.64 SRD5A1 (0.45) ALDH1A1TP53PPOXS100A4CA1
SCHEMBL120476 0.63 THRB (0.53) ALDH1A1TP53PPOXS100A4CA1
SCHEMBL30633032 0.62 S100A4 (0.41) MEN1KMT2ATP53PPOXTYMS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110196175-A1 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts FMC CORPORATION 2011-08-11 US disclosed
US-7939685-B2 Hydroxylation of β-dicarbonyls with zirconium catalysts E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-05-10 US disclosed
US-7414157-B2 Hydroxylation of β-dicarbonyls with zirconium catalysts E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196175-A1 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts CBR3, CBR1, NOXO1 MEN1 4225/4885KMT2A 1506/4885ALDH1A1 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.